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Abstracts
data from a large general practitioner medical records da-
tabase (DINLINK) for the years 1992-1997 was used to
estimate the determinants of antidepressant drug use pat-
terns for 6,007 patients with a "new" episode of anti-
depressant therapy who were prescribed one of three most
often prescribed SSRIs: paroxetine, sertraline, or fluoxe-
tine. Using an insurance claims database, we study antide-
pressant use patterns over a twelve month follow-up pe-
riod for individual patients described as having depression
and who initiated pharmacotherapy on tricyclic antide-
pressants, or the SSRIs sertraline, paroxetine, or fluoxetine
in an outpatient setting in the United States between 1990
. and 1994.
RESULTS: Patients who initiated therapy on sertraline or
paroxetine were less likely than patients who initiated
therapy on fluoxetine to have four or more 30-day pre-
scriptions of their initial antidepressant within the first
six months. The magnitude of these differences was
greater for patients who initiated SSRI therapy between
1995 and 1997, as compared to 1992 through 1994.
CONCLUSION: There is increasing evidence that antide-
pressant use patterns differ across TCAs and individual
SSRIs in the actual clinical practice setting. The findings
suggest that the particular SSRI selected is an important
determinant of use consistent with current recommended
depression treatment guidelines in primary care in the
United Kingdom.
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This study analyzed antidepressant utilization and de-
pression diagnoses among patients who initiated antide-
pressant therapy in mid-1995 through a national man-
aged care organization (MCa) and its behavioral health
component.
OBJECTIVE: The purpose of this study was to evaluate
antidepressant usage in 31 managed care plans nation-
wide as part of a national quality assurance program to
understand and improve utilization of antidepressants
and the overall quality of care provided to patients.
METHODS: A retrospective analysis was conducted us-
ing prescription, diagnoses, and eligibility databases of
the national Mca and its behavioral health component.
Adults who were continuously eligible for medical and
pharmacy benefits during the study period and received
one or more prescriptions for one of 20 antidepressants
during April 1, 1995 through August 31,1995 were con-
sidered for selection. Duration of therapy, titration, and
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switching/augmentation patterns were evaluated in the
nine months following therapy initiation.
RESULTS: The cross-sectional analysis revealed that 77%
of all antidepressant prescriptions were written by primary
care providers, and 58% of all antidepressant prescriptions
did not have a primary or secondary depression diagnosis.
SSRIs were clearly the drug of choice and had a more sus-
tained length of treatment, but average days of continuous
therapy did not meet AHCPR guidelines of minimum du-
ration (i.e., four months). Switching was most frequent for
those patients who failed a TCA or trazodone.
CONCLUSION: As a result of these findings, the man-
aged care organization's behavioral health component
implemented intervention measures aimed at improving
care by physicians. Due to the success of this collabora-
tive effort, additional studies between the MCa, its be-
havioral health component, and PCS are under way.
